StockChartsAI.com
All Chart Prices Delayed at least 15 minutesBefore accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 9.5
Power Rank trend -> Rising
01/17/2025 16:28:00 EST
Hims Hers Health Inc (HIMS)
Industry: Household & Personal Products
Follow @stockchartsai on TwitterPrice Support Resistance
In the past 20 trading days, HIMS has been trading in a range between $28.55 and $24.18 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
The AI powered stock chart is in a Red zone currently. We would avoid this stock.
Upside / Downside Potential
Hims Hers Health Inc $HIMS entered a Red zone 20 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $26.1964, a potential down side of -5.73% from the recent price of 27.79. The stock is trading 26.02% (potential upside) below its 52 week high of $35.02 and 229.27 % (potential downside) above its 52 week low of $8.44 - based on the recent price.
Company Summary
Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
News
| Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today A shake-up may be brewing in the market for GLP-1 diet drugs Friday, and it's making itself felt all across the field of companies selling (or hoping to sell) semaglutide and related drugs for treating diabetes and losing weight. As of 11 a.m. Source: The Motley Fool Fri, 17 Jan 2025 11:37:08 -0500 Sentiment: Negative |
| Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. Source: MarketBeat Fri, 17 Jan 2025 08:15:35 -0500 Sentiment: Positive |
| Is Hims & Hers Stock in Trouble? Hims & Hers Health (HIMS 6.30%) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. The telehealth company has been growing at a fast rate, making it one of the best stocks to own in healthcare of late. Source: The Motley Fool Thu, 16 Jan 2025 06:22:00 -0500 Sentiment: Positive |
| Hims & Hers Health, Inc. (HIMS) Laps the Stock Market: Here's Why Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $25.90, moving +1.93% from the previous trading session. Source: Zacks Investment Research Mon, 13 Jan 2025 18:51:09 -0500 Sentiment: Neutral |
| Hims & Hers Stock Is Poised for a Major Surge in 2025 Hims & Hers (HIMS -4.02%) has been on a wild journey over the past year as GLP-1s drive both big gains and big losses for the stock. But the business is about much more than just one product, and Travis Hoium explains why investors should expect an expanded platform in 2025. Source: The Motley Fool Fri, 10 Jan 2025 11:30:16 -0500 Sentiment: Positive |
Technicals 52 Week Hi: 35.02 52 Week Low: 8.44 Beta: 1.062 50 Day MA: 27.347 200 Day MA: 20.2116 Earnings / Revenue Trends Qtr Earnings Growth YOY: 0 Qtr Revenue Growth YOY: 0.771 Forward PE: 57.4713 Trailing PE: 63.2955